It reduces insulin resistance by increasing the sensitivity of cells to insulin
DEAR MAYO CLINIC: It seems like all I hear in the entertainment world these days is yet another celebrity shedding pounds on a weight-loss drug
Weight Management with Breakthrough GLP-1 Innovation GLP-1 Formula utilizes advanced bioactive compounds to modulate the gut-endocrine axis, specifically enhancing the endogenous secretion of glucagon-like peptide-1 (GLP-1) from intestinal L-cells
The Journal of Nutrition , 134 (3): 489-492
When measured 120 min after olanzapine, our triple treatment significantly increased active GLP1 in serum (Mean SD: Vehicle-Control = 5.36 0.99, Olanzapine-Control = 6.33 1.53, Vehicle-TriTreatment = 36.81 7.93, Olanzapine-TriTreatment = 54.29 17.67
The endocrinologist I have spoken with regularly about this has mentioned that semaglutide is more muscle sparing than Mounjaro, which raises interesting points about how wide this market may be in terms of each modality perhaps retaining a market share for a very specific type of body composition requirement